Differential effect of triglycerides on the prognosis of patients with a first versus recurrent acute coronary syndrome

  • 0Cardiology Department, Hospital Universitario de San Juan, Alicante, Spain.

Summary

This summary is machine-generated.

Triglyceride levels impact cardiovascular events differently based on prior acute coronary syndrome (ACS) history. Previous ACS modifies the risk, suggesting triglycerides may be a treatment target with varied benefits for first or recurrent ACS patients.

Area Of Science

  • Cardiology
  • Clinical Research
  • Public Health

Background

  • Conflicting evidence exists regarding the role of triglycerides in cardiovascular prevention.
  • Potential confounding factors may explain the divergent findings on triglyceride impact.

Purpose Of The Study

  • To investigate the association between triglyceride levels and cardiovascular outcomes in patients discharged after acute coronary syndrome (ACS).
  • To determine if previous ACS history modifies the effect of triglycerides on major adverse cardiovascular events (MACE) and mortality.

Main Methods

  • A multicenter, retrospective study involving 14,483 patients hospitalized with ACS across 8 Spanish hospitals.
  • Triglyceride levels were measured during hospitalization, with follow-up analysis of mortality and MACE.
  • Multivariate analysis was used to assess the association between triglycerides and outcomes, with interaction analyses for previous ACS.

Main Results

  • Triglyceride levels were associated with an increased risk of MACE (HR 1.01) but not all-cause mortality.
  • A significant interaction between triglycerides and previous ACS was observed for both MACE and mortality.
  • Triglycerides increased MACE risk in recurrent ACS patients (HR 1.03) and mortality risk in first ACS patients (HR 1.02).

Conclusions

  • Previous ACS status significantly alters the impact of triglycerides on MACE and mortality in post-ACS patients.
  • Triglycerides may represent a therapeutic target for patients with first or recurrent ACS.
  • The expected benefits of triglyceride-lowering treatments may differ between first-time and recurrent ACS events.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile 01:25

108

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers 01:20

71

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents 01:20

475

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...